Medicines regulator to allow limited use of ivermectin for Covid-19 patients
Ivermectin is a cheap, off-patent, anti-parasitic drug not registered for human use in SA, but which has piqued the interest of researchers
27 January 2021 - 15:36
SA’s medicines regulator will allow doctors to prescribe ivermectin for coronavirus patients under a tightly controlled “compassionate use” programme, while it waits for stronger evidence to emerge from ongoing clinical trials, it announced on Wednesday.
Ivermectin is a cheap, off-patent, anti-parasitic drug that has not been registered for human use in SA. It has piqued the interest of researchers as a potential treatment for Covid-19, but regulators around the world have consistently said there is not yet enough data to confirm its safety and efficacy...
BL Premium
This article is reserved for our subscribers.
A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now